Drawing for PHARMASTER

USPTO serial 79069417

PHARMASTER

Reviewed by CopyMark Law Group

Reg. 3763469Status 404
Filing date
Status date
Registration date
Mar 23, 2010
Examiner
LEE, DOUGLAS
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHARMASTER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003Cosmetic products in the nature of aerosols for freshening breath, cosmetics, cosmetics for animals, cosmetic creams and lotions, cosmetics for skin care not for medical purposesSECTION 71 - CANCELLED—
005Medicines for human and veterinary use, for the treatment of infectious diseases affecting the eyes, ears, nose, mouth and throat pharmaceutical products for treating skin conditions; aerosol dispensers and spray containing pharmaceutical preparations for treating infectious diseases affecting the nose, throat, ears and skinSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 18, 2019DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Oct 18, 2019DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 24, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 4, 2017INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 6, 2017INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 6, 2017INPCINVALIDATION PROCESSED—
Jun 28, 2017INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 28, 2016C71TCANCELLED SECTION 71—
Sep 15, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 15, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 13, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 13, 2010FIMPFINAL DISPOSITION PROCESSED—
Jun 24, 2010FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 23, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 5, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 16, 2009NPUBNOTICE OF PUBLICATION—
Nov 29, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 23, 2009CNEAEXAMINERS AMENDMENT MAILED—
Nov 23, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 23, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Nov 23, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 20, 2009ACECAMENDMENT FROM APPLICANT ENTERED—
Nov 20, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 20, 2009ALIEASSIGNED TO LIE—
Nov 9, 2009MAILPAPER RECEIVED—
Aug 14, 2009RFNPREFUSAL PROCESSED BY IB—
Jul 10, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 10, 2009RFRRREFUSAL PROCESSED BY MPU—
Jul 10, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 10, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 9, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 6, 2009DOCKASSIGNED TO EXAMINER—
Jul 6, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 2, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance